AimsPeople who have schizophrenia die earlier from somatic diseases than do people in
the general population, but information about cardiovascular deaths in people who have …

OBJECTIVE: The aim of the study is to review the absolute and relative impacts of the major
causes for premature mortality among patients with schizophrenia. DATA SOURCES: We …

Background: Studies have shown that patients with schizophrenia have higher rates of
cardiovascular disease and mortality compared with the general population. However …

Objective Schizophrenia is associated with premature mortality, but the specific causes and
pathways are unclear. The authors used outpatient and inpatient data for a national …

OBJECTIVE: To evaluate the prevalence of cardiovascular risk factors (CV-RF) and disease
(CV-D) in people with schizophrenia. METHOD: We conducted a period-prevalence study …

BackgroundPatients with schizophrenia have excess cardiovascular morbidity and mortality.
Previous studies suggest that this may be partly due to inadequate somatic treatment and …

The objective of the study was to analyse 10-year mortality among persons with
schizophrenia from an epidemiological perspective. This cohort study included all persons …

This study compared the risks of cardiovascular morbidity and mortality in people with
schizophrenia who use antipsychotic medications to risks in individuals without …

Patients with schizophrenia have higher level of mortality and physical comorbidity
compared to control population. However the association to primary-, secondary-and tertiary …

Background: Cardiovascular disease (CVD) mortality in schizophrenia is more frequent than
in the general population. Whether second-generation antipsychotics (SGAs) increase risk …